Pubblicazioni

Translational implications for radiosensitizing strategies in rhabdomyosarcoma

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pomella, Silvia; Porrazzo, Antonella; Cassandri, Matteo; Camero, Simona; Codenotti, Silvia; Milazzo, Luisa; Vulcano, Francesca; Barillari, Giovanni; Cenci, Giovanni; Marchese, Cinzia; Fanzani, Alessandro; Megiorni, Francesca; Rota, Rossella; Marampon, Francesco

MSâ275 (Entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cassandri, M.; Pomella, S.; Rossetti, A.; Petragnano, F.; Milazzo, L.; Vulcano, F.; Camero, S.; Codenotti, S.; Cicchetti, F.; Maggio, R.; Festuccia, C.; Gravina, G. L.; Fanzani, A.; Megiorni, F.; Catanoso, M.; Marchese, C.; Tombolini, V.; Locatelli, F.; Rota, R.; Marampon, F.

Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996

2021 - AMERICAN JOURNAL OF HEMATOLOGY

Piciocchi, A.; Messina, M.; Elia, L.; Vitale, A.; Soddu, S.; Testi, A. M.; Chiaretti, S.; Mancini, M.; Albano, F.; Spadano, A.; Krampera, M.; Bonifacio, M.; Cairoli, R.; Vetro, C.; Colella, F.; Ferrara, F.; Cimino, G.; Bassan, R.; Fazi, P.; Vignetti, M.

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network

2019 - HEMATOLOGICAL ONCOLOGY

Della Starza, I.; Cavalli, M.; De Novi, L. A.; Genuardi, E.; Mantoan, B.; Drandi, D.; Barbero, D.; Ciabatti, E.; Grassi, S.; Gazzola, A.; Mannu, C.; Agostinelli, C.; Piccaluga, P. P.; Bomben, R.; Degan, M.; Gattei, V.; Guarini, A.; Foa, R.; Galimberti, S.; Ladetto, M.; Ferrero, S.; Del Giudice, I.

The promoter-associated noncoding RNA PNCCCND1_B assembles a proteinâRNA complex to regulate cyclin D1 transcription in Ewing sarcoma

2019 - CANCER RESEARCH

Palombo, R.; Frisone, P.; Fidaleo, M.; Mercatelli, N.; Sette, C.; Paronetto, M. P.

Heterogeneity of PD-L1 expression and relationship with biology of NSCLC

2018 - ANTICANCER RESEARCH

Bassanelli, Maria; Sioletic, Stefano; Martini, Maurizio; Giacinti, Silvana; Viterbo, Antonella; Staddon, Anita; Liberati, Fabrizio; Ceribelli, Anna

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group

2015 - HAEMATOLOGICA

D'AngiÃ², M; Valsecchi, Mg; Testi, Anna Maria; Conter, V; Nunes, Vittorio; Parasole, R; Colombini, A; Santoro, N; Varotto, S; Caniglia, M; Silvestri, D; Consarino, C; Levati, L; Magrin, E; Locatelli, F; Basso, G; Foa, Roberto; Biondi, A; Cazzaniga, G.

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy

2015 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto